DB
GMAB icon

Dmitry Balyasny’s Genmab GMAB Stock Holding History

Dmitry Balyasny’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-379,364
Closed -$11.7M – 3128
2025
Q4 		$11.7M Buy
+379,364
New +$11.8M 0.01% 955
2024
Q4 		– Sell
-212,663
Closed -$5.18M – 2935
2024
Q3 		$5.18M Buy
+212,663
New +$5.69M 0.01% 1236
2023
Q4 		– Sell
-26,552
Closed -$936K – 2638
2023
Q3 		$936K Buy
26,552
+18,963
+250% +$723K ﹤0.01% 1582
2023
Q2 		$288K Buy
+7,589
New +$303K ﹤0.01% 1997
2023
Q1 		– Sell
-25,006
Closed -$1.06M – 2842
2022
Q4 		$1.06M Sell
25,006
-25,413
-50% -$1.05M ﹤0.01% 1632
2022
Q3 		$1.62M Buy
+50,419
New +$1.77M 0.01% 1589
2020
Q4 		– Sell
-14,591
Closed -$534K – 1472
2020
Q3 		$534K Buy
+14,591
New +$528K ﹤0.01% 1097
2020
Q2 		– Sell
-23,179
Closed -$491K – 1265
2020
Q1 		$491K Sell
23,179
-17,520
-43% -$391K 0.01% 911
2019
Q4 		$909K Buy
+40,699
New +$888K 0.01% 900

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dmitry Balyasny's GMAB Position: Q1 2026 in Review

Dmitry Balyasny sold out of Genmab (GMAB) in Q1 2026, closing a stake of 379,364 shares — an estimated $11.7M sold.

Dmitry Balyasny first reported a position in GMAB in Q4 2019 and held it in 9 quarters. The position peaked at $11.7M in Q4 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Dmitry Balyasny reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 379,364 Genmab shares in Q1 2026, an estimated $11.7M.
  • Dmitry Balyasny first reported a position in Genmab in Q4 2019 and held it in 9 quarters.
  • Dmitry Balyasny's Genmab position peaked at $11.7M in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.